High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 7, Issue 11, Pages 5525-5533
Publisher
Wiley
Online
2018-10-25
DOI
10.1002/cam4.1833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
- (2017) Julia Mayerle et al. GUT
- Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
- (2017) Eric J. Duell et al. INTERNATIONAL JOURNAL OF CANCER
- Cigarette Smoking and Pancreatic Cancer Survival
- (2017) Chen Yuan et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis
- (2017) M. Giulietti et al. CELLULAR ONCOLOGY
- Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
- (2017) Haizhen Lu et al. Cancer Medicine
- A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study
- (2016) Sukhwinder Kaur et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
- (2016) Hisashi Hara et al. BRITISH JOURNAL OF CANCER
- Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
- (2016) J S Ankeny et al. BRITISH JOURNAL OF CANCER
- Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer
- (2016) Yuichiro Kato et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
- (2016) Francesca Riva et al. Molecular Oncology
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- Autoimmune response to PARP and BRCA1/BRCA2 in cancer
- (2015) Qing Zhu et al. Oncotarget
- Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer
- (2015) Su-xia Han et al. Oncotarget
- Novel insights into Notum and glypicans regulation in colorectal cancer
- (2015) Mariangela De Robertis et al. Oncotarget
- Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer
- (2014) A. Chan et al. CLINICAL CANCER RESEARCH
- GPC1 Regulated by miR-96-5p, Rather than miR-182-5p, in Inhibition of Pancreatic Carcinoma Cell Proliferation
- (2014) Chunlong Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
- (2013) Hideaki Shimada et al. Gastric Cancer
- GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer
- (2012) Lian Duan et al. Asian Journal of Surgery
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis
- (2011) C A Whipple et al. ONCOGENE
- Immunodiagnostic Value of Combined Detection of Autoantibodies to Tumor-associated Antigens as Biomarkers in Pancreatic Cancer
- (2011) J. Li et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
- (2008) Takuma Aikawa et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search